Department of Life Science, Hanyang University, Seoul, 04763, Republic of Korea.
Department of HY-KIST Bio-Convergence, Hanyang University, Seoul, 04763, Republic of Korea.
Exp Mol Med. 2021 Apr;53(4):495-504. doi: 10.1038/s12276-021-00599-7. Epub 2021 Apr 8.
Photodynamic therapy (PDT) has been considered a noninvasive and cost-effective modality for tumor treatment. However, the complexity of tumor microenvironments poses challenges to the implementation of traditional PDT. Here, we review recent advances in PDT to resolve the current problems. Major breakthroughs in PDTs are enabling significant progress in molecular medicine and are interconnected with innovative strategies based on smart bio/nanomaterials or therapeutic insights. We focus on newly developed PDT strategies designed by tailoring photosensitive reactive oxygen species generation, which include the use of proteinaceous photosensitizers, self-illumination, or oxygen-independent approaches. While these updated PDT platforms are expected to enable major advances in cancer treatment, addressing future challenges related to biosafety and target specificity is discussed throughout as a necessary goal to expand the usefulness of PDT.
光动力疗法(PDT)被认为是一种非侵入性且具有成本效益的肿瘤治疗方法。然而,肿瘤微环境的复杂性给传统 PDT 的实施带来了挑战。在这里,我们综述了 PDT 的最新进展,以解决当前的问题。PDT 的主要突破正在推动分子医学的重大进展,并与基于智能生物/纳米材料或治疗见解的创新策略相互关联。我们专注于通过定制光敏性活性氧生成而设计的新型 PDT 策略,包括使用蛋白质类光敏剂、自照明或与氧无关的方法。虽然这些更新的 PDT 平台有望为癌症治疗带来重大进展,但我们还讨论了与生物安全性和靶向特异性相关的未来挑战,这是扩大 PDT 用途的必要目标。